TSI Health Sciences Expands European Presence, Opens its First UK Office
Adrian Lindridge named European sales director. Lindridge will be responsible for creating and implementing comprehensive sales and marketing strategies.
19/07/06 TSI Health Sciences, a leading developer, producer and marketer of nutraceutical and pharmaceutical ingredients, today announced the opening of its first sales and marketing office in Europe. Adrian Lindridge has been appointed sales director, Europe, and will be based out of the new office in Rochdale, Lancashire, UK.
"Demand for high quality nutraceutical ingredients in Europe has steadily increased over the past few years," said Larry Kolb, TSI Health Sciences president, U.S. operations. "TSI has established a presence in this market and we've realized we needed an office in Europe to build upon our momentum. This office will allow us to better serve our existing clients and increase our customer base."
Lindridge will be responsible for creating and implementing comprehensive sales and marketing strategies to educate European ustomers on the company and its extensive product lines. Prior to joining TSI, Lindridge worked for SSL International plc, a global consumer healthcare company.
During his 18 years of employment with SSL, Lindridge held many positions, including head of the OTC business development, director of UK consumer marketing and marketing manager, Europe. Lindridge has an MBA from University of Bradford and a bachelor's degree in physiology from University of Leeds.
